Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL675P (“RNA, 7SL, cytoplasmic 675, pseudogene”) is a pseudogene derived from the 7SL RNA gene family, which encodes the RNA component of the signal recognition particle (SRP), a ribonucleoprotein complex essential for targeting secretory proteins to the endoplasmic reticulum[5][4]. In humans, while a few RN7SL genes are functional and have important roles in protein translocation and cellular signaling, the vast majority—including RN7SL675P—are non-functional genomic copies (pseudogenes) that do not produce RNA or functional product[4][5]. Pseudogenes of 7SL RNA are numerous, generated via reverse transcription and integration of 7SL RNA-derived sequences into the genome. These loci generally have no known regulatory, structural, or direct therapeutic target role; rather, they are markers of genomic evolution and activity of retrotransposition[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 675, pseudogene (RN7SL675P).